|Autolus Therapeutics PLC ADR||22.56 %|
|Blue Earth Diagnostics||16.33 %|
|Nightstar Therapeutics PLC ADR||14.60 %|
|Freeline Therapeutics||6.59 %|
|The Sfp Value Realization||3.33 %|
|Polar Capital UK Absolute Eq I EUR||2.91 %|
|Maga Smaller Companies UCITS EUR Acc||2.44 %|
|AKO Global UCITS A2 USD Acc||2.33 %|
|Portland Hill European Long/Short B GBP||1.58 %|
|Permira V||1.55 %|
|United Kingdom||97.89 %|
McDonald has been a vice president and associate portfolio manager with Phoenix Investment Counsel since 1992. He joined the company in 1990 as a marketing coordinator for investment communications, and became a research analyst in 1991. McDonald began his career in 1989 as a financial services advisor for The America Group. McDonald earned his Chartered Financial Analyst designation in 1994. He was born November 29, 1967 in Waterbury, Connecticut.
Data provided by Morningstar.
The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Money Observer and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.
This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.
You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.